AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06416579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Schroth Exercise Group
Description: Exercises will be given in lying, sitting and standing positions. In each exercise, elongation of the spine will be ensured and the person will be positioned according to the type of scoliosis. Exercises will be given progressively in supine, prone, side sitting, sitting and standing positions. In each exercise, elongation of the spine will be ensured and the person will be positioned according to the upper and lower extremities. The exercise program will be divided into 4 phases: 0-4, 5-8, 9-12, 12-24. Progress in the exercises will be made positionally by increasing the number of repetitions and the number of rotational breathing during the exercise.
Study NCT06416579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Schroth Method Based Virtual Reality Group
Description: During Schroth method-based virtual reality exercises, continuity in stabilization will be ensured by using external focus and muscular activation in positions appropriate to the Schroth method and in corrected posture. Sessions will last 40 minutes in total, including 5 minutes of warm-up, 30 minutes of balance and sports games, and 5 minutes of cool-down. Warm-up and cool-down will consist of aerobic games available in Nitendo wii. Balance games will consist of Penguin Slide, Soccer Heading, Table Tilt, Balance Bubble, Ski Slalom, Ski Jump, Tilt City and Snowboard Slalom. Among the sports games, Bowling, Boxing, Tennis and Baseball will be included in the program. Progression will be made by difficulty level and positional in all games. The exercises will be made more difficult by side sitting, side sitting on a stool, sitting position, knight position, standing, sitting on a balance ball, standing on a soft floor, on a bosu ball and moving towards the balance board.
Study NCT05373927 — intervention group
Intervention type: DEVICE
Intervention: Multispectral Optoacoustic Tomography (MSOT)
Description: Non-invasive transcutaneous imaging of subcellular muscle components via infrared and near-infrared laser pulses
Study NCT06416579 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Participants in the control group will be placed on a waiting list for 24 weeks. Participants will not receive any exercise intervention for 24 weeks and will be able to continue their routine physical activities.
Study NCT06211959 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Approach Bias Modification with Implementation Intentions
Description: Participants in each experimental condition will perform different variants of the Approach-Avoidance Task (i.e., a task that is widely used in the litterature to assess and modify the approach bias toward alcohol - the relative ease to approach alcohol rather than to avoid it). Participants in the classical Approach Bias Modification conditions will perform a version of this task which will train them to (almost-)systematically emit an avoidance response toward alcohol ; Participants in the Approach Bias Modification with Implementation Intentions condition will perform the same version of the task but will additionnaly have to complete a planning intervention (i.e., implementation intentions) to help them avoiding alcohol; Participants in the Sham-training condition will perform a version of this task which require them to approach alcohol as often as they have to avoid it (i.e., no real training).
Study NCT05573074 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Photobiomodulator
Description: Transcranial photobiomodulator delivers Near-Infrared Radiation (NIR) continuous middle irradiance (291.7 mW/cm2) to patients' foreheads.
Study NCT05573074 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Photobiomodulator
Description: Transcranial photobiomodulator delivers Near-Infrared Radiation (NIR) continuous middle irradiance (291.7 mW/cm2) to patients' foreheads.
Study NCT05573074 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sham
Description: Transcranial Photobiomodulator delivers sham irradiance odes of 0 mW/cm2
Study NCT05573074 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham
Description: Transcranial Photobiomodulator delivers sham irradiance odes of 0 mW/cm2
Study NCT06211959 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Approach Bias Modification with Implementation Intentions
Description: Participants in each experimental condition will perform different variants of the Approach-Avoidance Task (i.e., a task that is widely used in the litterature to assess and modify the approach bias toward alcohol - the relative ease to approach alcohol rather than to avoid it). Participants in the classical Approach Bias Modification conditions will perform a version of this task which will train them to (almost-)systematically emit an avoidance response toward alcohol ; Participants in the Approach Bias Modification with Implementation Intentions condition will perform the same version of the task but will additionnaly have to complete a planning intervention (i.e., implementation intentions) to help them avoiding alcohol; Participants in the Sham-training condition will perform a version of this task which require them to approach alcohol as often as they have to avoid it (i.e., no real training).
Study NCT05750771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DES
Description: Second-generation drug-eluting stents
Study NCT05750771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DCB
Description: Drug-coated balloon with paclitaxel as drug coating
Study NCT06367257 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: App Usage
Description: Conducting patient surveys with app
Study NCT06367257 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: supportive care during and after radio(chemo)therapy according to hospial standards
Study NCT06488131 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MTA Pulpotomy
Description: Complete coronal MTA pulpotomy.
Study NCT06488131 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Root Canal Treatment
Description: Conventional root canal treatment.
Study NCT04845828 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node mapping
Description: Laparoscopic or robotic hysterectomy with/without bilateral salpingo-oophorectomy 2. Inject 1.25 mg/ml of ICG and a total of 6ml into the cornual area (0.5-1 cm deep) of the uterus. And then inject 1 ml of mucous membrane (1-3 mm deep) and 1 ml of substrate (1-2 cm deep) into the cervix, and a total of 4 ml in each direction of 3 and 9 o'clock.~3. Sentinel lymph node is excised
Study NCT04845828 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Routine lymph node dissection
Description: 1. Laparoscopic or robotic hysterectomy with/without bilateral salpingo-oophorectomy~2. Lymph node detection is performed.
Study NCT05933239 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 68GaNOTA-Anti-MMR-VHH2
Description: Injection of the radiopharmaceutical and PET/CT imaging
Study NCT04994002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CERC-006
Description: Oral solution
Study NCT05626998 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: The participants will receive intramuscular dexmedetomidine injection (1 µg/kg) diluted in 2ml normal saline thirty minutes before surgery in the ward.
Study NCT05689580 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: The course of the trial to medium-chain triglyceride lipid intervening 50-70% of dietary intake
Study NCT05626998 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gabapentin
Description: The participants will receive 600 mg gabapentin (two capsules each containing 300 mg) thirty minutes before surgery in the ward
Study NCT05689580 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Balanced diet
Description: Balanced diet
Study NCT06520085 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: interactive mHealth application for patients undergoing RSA
Description: Patients will receive interactive information via an mHealth application tailored to their needs and progress during the rehabilitation period after RSA.
Study NCT06520085 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: interactive mHealth application for patients undergoing RSA
Description: Patients will receive interactive information via an mHealth application tailored to their needs and progress during the rehabilitation period after RSA.
Study NCT05314608 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: IntraOsseous BioPlasty® (IOBP®) Surgical Technique into the knee
Description: Injection of a biologic mixture (BMC and allograft) into the subchondral bone lesion
Study NCT05288283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GWP42003-P
Description: oral solution
Study NCT05288283 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral solution
Study NCT05988060 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Intervention
Description: Patients who were randomized in the PEI group and accepted the invitation to undergo the experimental intervention receive a PEI for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT. The PEI consists of a 60 minutes intervention twice a week and will be supervised by a physiotherapist specialized in oncology.~Patients who receive the intervention also have to do home-based aerobic and muscle strength exercises by themselves three times a week.
Study NCT06053515 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rosie the Chatbot
Description: Participants in the intervention group will be using the chatbot to ask questions related to the mom and baby's health, provide feedback selecting thumbs up or thumbs down on the questions' response, and use the features (video library, resources page, frequently asked questions (FAQ), and daily syllabus). In addition, participants will be taking a pre-test health survey, mid-test health survey, and post-test health survey.
Study NCT05541809 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aromatherapy
Description: Peppermint aroma inhalation
Study NCT05541809 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Water inhalation
Study NCT06035900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocin
Description: single 4mg dose of psilocin mucate was administered to healthy 10 volunteers
Study NCT05936450 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: delivery of placentrex gel after open flap debridement
Description: placentrex gel is placed after open flap debridement only in the test group
Study NCT05936450 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open Flap Debridement
Description: Open Flap Debridement done in both test and control groups
Study NCT05936450 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Open Flap Debridement
Description: Open Flap Debridement done in both test and control groups
Study NCT06073496 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: Patient receive analgetic medicine will get experimental procedure with needle insertion that attach to eletrostimulator
Study NCT05299437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Radioiodine optimized therapy
Description: 124-I blood and lesion dosimetry will be used to optimize the 131-I therapeutic activity. Both 124-I and 131-I administration will be performed after hormon withdrawal.~Primary tumour tissue and circulating miRNA will be analyzed to check the genetic status.
Study NCT05343286 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: blood sample
Description: blood sample before and after 12 weeks of physical activity
Study NCT05343286 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: blood sample
Description: blood sample before and after 12 weeks of physical activity
Study NCT05343286 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: blood sample
Description: blood sample before and after 12 weeks of physical activity
Study NCT05343286 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: physical assessement
Description: physical assessement before and after 12 weeks of physical activity~* Standardized geriatric assessment (physician visit)~* ICOPE Monitor Assessment~* Sit-to-stand Test~* Quantified Gait Analysis (QAM)~* Bone densitometer measurement of body composition
Study NCT05343286 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physical assessement
Description: physical assessement before and after 12 weeks of physical activity~* Standardized geriatric assessment (physician visit)~* ICOPE Monitor Assessment~* Sit-to-stand Test~* Quantified Gait Analysis (QAM)~* Bone densitometer measurement of body composition
Study NCT05343286 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: physical assessement
Description: physical assessement before and after 12 weeks of physical activity~* Standardized geriatric assessment (physician visit)~* ICOPE Monitor Assessment~* Sit-to-stand Test~* Quantified Gait Analysis (QAM)~* Bone densitometer measurement of body composition
Study NCT05343286 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: psychometric assessment
Description: Psychometric questionnaires~* Cognitive tests (MMSE)~* The long questionnaire of personality traits: Big Five Inventory~* Perceived health and subjective age~* Age group identification~* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale~* Physical self-perception: French version of the Physical Self-Perception Profile~* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context~* Aging Stereotypes and Exercise Scale
Study NCT05343286 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychometric assessment
Description: Psychometric questionnaires~* Cognitive tests (MMSE)~* The long questionnaire of personality traits: Big Five Inventory~* Perceived health and subjective age~* Age group identification~* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale~* Physical self-perception: French version of the Physical Self-Perception Profile~* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context~* Aging Stereotypes and Exercise Scale
Study NCT05343286 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: psychometric assessment
Description: Psychometric questionnaires~* Cognitive tests (MMSE)~* The long questionnaire of personality traits: Big Five Inventory~* Perceived health and subjective age~* Age group identification~* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale~* Physical self-perception: French version of the Physical Self-Perception Profile~* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context~* Aging Stereotypes and Exercise Scale
Study NCT04772261 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 13C-Spirulina GEBT
Description: Various lots of 13C-Spirulina GEBT test meals
Study NCT05899244 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: muscle streching exercice
Description: For this exercice the participant will have to place the foot of the stretched leg on a step while maintaining his knee in extension.~From this starting position the patient will have to do a pelvic anterior tilt while keeping is back straight and his gaze horizontal until the movement induce a feeling of stretching in the posterior part of the thigh.
Study NCT05899244 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Slider
Description: In order to define the starting position for a slider, the participant will be positioned in lateral decubitus with the knee extended and will perform a hip flexion until a sensation of pain or stretching feeling appears on the posterior part of the thigh or of the knee. If the hip flexion does not induce a stretching sensation or pain, a dorsal ankle flexion is added. Once this position is defined the patient slightly reduces the amount of hip flexion until the stretching/pain sensation disappears.~From this starting position, to perform the slider: the subject performs a hip flexion movement and simultaneously a cervical extension movement, this corresponds to the outward movement. For the return movement the patient performs a hip extension and at the same time a cervical flexion. The slider technique must be pain free.
Study NCT05899244 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tensioner
Description: The participant will be positioned in lateral decubitus with the knee extended and the hip, the cervical, thoracic and lumbar spine placed in neutral position.~For the outward movement, the participant will perform a hip flexion associated with a simultaneous movement of cervical extension until a sensation of pain or a stretching feeling appears on the posterior part of the thigh or of the knee.If this combined movements do not induce a stretching sensation or pain, a dorsal flexion of the ankle is added.~For the return movement, the participant will realize a hip extension simultaneously associated to a movement of extension of the cervical spine. If the dorsal flexion of the ankle was used during the outward movement, a movement plantar flexion of the ankle must be used in association to the movement of hip extension.
Study NCT05075070 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated COVID-19 vaccine
Description: two doses inactivated COVID-19 vaccine
Study NCT06156982 — intervention group
Intervention type: DRUG
Intervention: Evusheld
Description: Administration of Evusheld 600 mg
Study NCT05098795 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Description: BA seeks to increase the positive reinforcement patients experience from their natural environment by promoting prosocial and valued experiences. BA has been found to improve substance use treatment retention and adherence, as well as medication adherence in low-income individuals with HIV/AIDS.
Study NCT06342193 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality group
Description: This group will use virtual reality glasses as distraction during cystoscopy.
Study NCT05201664 — intervention group
Intervention type: PROCEDURE
Intervention: Surgical Extrusion
Description: Relocation of the remaining tooth structure to a more coronal position within the same original socket.
Study NCT05547204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beverage
Description: Free from added carbohydrates (contain 1g CHO only) and electrolytes are absent.
Study NCT05547204 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Beverage
Description: Free from added carbohydrates (contain 1g CHO only) and electrolytes are absent.
Study NCT04986956 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whole coffee cherry extract
Description: 200mg WCCE
Study NCT04986956 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for comparison to WCCE
Study NCT06342778 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxylamine + Pyridoxine
Description: A single dose of R or T drug in each of 2 periods of the study after meals
Study NCT06342778 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxylamine + Pyridoxine
Description: A single dose of R or T drug in each of 2 periods of the study after meals
Study NCT03872986 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SDF
Description: Combined Silver Diamine Fluoride (SDF) and Potassium Iodide (KI)
Study NCT06342778 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclectin
Description: A single dose of R or T drug in each of 2 periods of the study after meals
Study NCT06342778 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclectin
Description: A single dose of R or T drug in each of 2 periods of the study after meals
Study NCT03872986 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Giomer
Description: Beautifil II dental restorative material
Study NCT03872986 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GIC
Description: Equia forte dental restorative material
Study NCT05306119 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation method
Description: Application of techniques of kinesiotherapy, electrotherapy, massage in comorbid patients and patients with low back pain who had undergone myocardial revascularization surgery in main group.
Study NCT05513209 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: opioid based multimodal anesthesia
Description: elective tonsillectomy or adenotonsillectomy surgery using opioid based multimodal anesthesia.
Study NCT05513209 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pterygopalatine ganglion block based multimodal anesthesia)
Description: elective tonsillectomy or adenotonsillectomy surgery using opioid free pterygopalatine ganglion block based multimodal anesthesia.
Study NCT06042517 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: OGTT with unlabeled glucose and liver NMR
Description: Subjects will undergo an OGTT with unlabeled glucose to measure liver glycogen concentration by NMR spectroscopy.
Study NCT06042517 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: OGTT with carbon-13 labeled glucose and liver NMR
Description: Subjects will undergo an OGTT with carbon-13 labeled glucose to measure liver glycogen synthesis rate by NMR spectroscopy.
Study NCT06042517 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CGM glucose reading
Description: A continuous glucose monitor (CGM) will be collecting glucose level changes over a 10-14day time period after the ultrasound.